Development of combinatorial drug against EGFR mutation in non-small cell lung cancer treatment
碩士 === 國立交通大學 === 分子醫學與生物工程研究所 === 102 === Oncologists are facing formidable challenges in overcoming cancers with either innate or acquired resistance to cancer therapies, especially for the cancers with EGFR mutation and activation. Therefore, the development of new drugs against drug resistance o...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | zh-TW |
| Published: |
2014
|
| Online Access: | http://ndltd.ncl.edu.tw/handle/46220197275366201244 |